Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Registration - In-house Corporation

sanofi-aventis Canada Inc. / Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)

Registration Information

In-house Corporation name: sanofi-aventis Canada Inc.
Previous in-house corporation names
Responsible Officer Name: Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO) 
Responsible Officer Change History
Initial registration start date: 2005-08-22
Registration status: Active
Registration Number: 951483-5180

Associated Communications

Total Number of Communication Reports: 121

Monthly communication reports in the last 6 months: 0

Version 6 of 40 (2008-02-29 to 2008-07-29)

Version 6 of 40 (2008-02-29 to 2008-07-29) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Responsible Officer and Corporation

Corporation: sanofi-aventis Canada Inc.
2150, blvd. St-Elzéar o.
Laval, QC  H7L 4A8
Canada
Telephone number: 514-956-6246
Fax number: 514-339-5149  
Responsible officer name and position during the period of this registration: Jérôme Silvestre, Président  
Description of activities: Compagnie de recherche pharmaceutique (production, vente et commercialisation)
 
The client is a subsidiary of the following parent companies: sanofi-aventis
174 avenue de France
Paris 75013
France

Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Corporation

Name: Myrtho-Emmanuelle Drouin
Position title: Chef, Politiques de Santé F/P/T et agences de remboursement
Public offices held: Yes
 
Name: Jérôme Silvestre
Position title: Président
Public offices held: No
 
Name: Joëlle Sissman
Position title: Vice-présidente, Affaires Publiques,Partenariats stratégiques institutionnels &Communications
Public offices held: No
 
Name: Michel G. Tremblay
Position title: Chef principal, Affaires fédérales
Public offices held: No
 

Public offices held: Myrtho-Emmanuelle Drouin

Adjointe spéciale, Affaires Parlementaires, Cabinet du Premier Ministre (1994-1999)

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Aboriginal Affairs and Northern Development Canada, Atlantic Canada Opportunities Agency (ACOA), Federal Office of Regional Development – Quebec (FORD[Q]), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Justice Canada (JC), Members of the House of Commons, National Defence (DND), National Research Council (NRC), Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Public Works and Government Services Canada, Veterans Affairs Canada (VAC), Western Economic Diversification Canada (WD)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Aboriginal Affairs, Health, Industry, Intellectual Property, Internal Trade, International Relations, International Trade, Justice and Law Enforcement, Regional Development, Science and Technology
 
Subject Matter: Retrospective: Rencontres )one-on-one) avec les ParlementairesRencontres avec les BureaucratesCommunications écrites
Subject Matter: Prospective: Rencontres (one-on-one) avec les ParlementairesRencontres avec les BureaucratesCommunications écrites
 

Details Regarding the Identified Subject Matter

Categories Description
Legislative Proposal Demander au ministère de la Santé de légiférer pour prévenir l'exportation en gros de médicaments vers les États-Unis ou vers toute autre juridiction
Legislative Proposal Renforcer la législation et la réglementation applicables en matière de propriété intellectuelle
Regulation Renforcer le Règlement sur les médicaments brevetés (avis de conformité)



Responsible Officer Name

This is the responsible officer name as provided in the most recent registration for the corporation or organization.

Name Change History:

sanofi-aventis Canada Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name From To
sanofi-aventis Canada Inc. 2008-07-29 current

The following names have been used before July 2, 2008

  • sanofi-aventis Canada Inc.
  • sanofi-aventis

Responsible Officer Change History

sanofi-aventis Canada Inc.

Responsible Officer History
Responsible Officer Name From (YYYY-MM-DD) To (YYYY-MM-DD)
Stephanie Veyrun-Manetti 2022-02-25 Current
Carrie McElroy 2021-09-16 2022-02-25
Marissa Poole 2020-09-17 2021-09-16
Niven Al-Khoury 2015-09-01 2020-09-17
Jonathan Fairest 2012-05-15 2015-09-01
Hugh O'Neill 2009-07-01 2012-05-15
Jérôme Silvestre 2005-08-22 2009-07-01

All Monthly Communication Reports for sanofi-aventis Canada Inc.

Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO) (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-121 of 121

  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Scott Simms, Député | House of Commons

    Subject Matter of the communication: International Trade, Intellectual Property, International Relations, Health, Science and Technology, Research and Development
    Communication date: 2016-03-21
    Posted date: 2016-04-20
    Communication number: 5180-375125 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Lametti, Député | House of Commons

    Subject Matter of the communication: International Trade, Intellectual Property, International Relations, Health, Science and Technology
    Communication date: 2016-03-15
    Posted date: 2016-04-20
    Communication number: 5180-375124 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Directeur Général | Innovation, Sciences et Développement Économique Canada | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: International Trade, Intellectual Property, International Relations, Health, Science and Technology, Research and Development
    Communication date: 2016-03-08
    Posted date: 2016-04-20
    Communication number: 5180-375126 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Chrystia Freeland, Ministre | Commerce international | Global Affairs Canada (GAC)

    Subject Matter of the communication: International Trade, Intellectual Property, International Relations, Science and Technology, Research and Development
    Communication date: 2016-03-03
    Posted date: 2016-04-20
    Communication number: 5180-375123 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Chrystia Freeland, Minister | International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, Intellectual Property, International Relations, Health, Science and Technology, Research and Development
    Communication date: 2016-03-03
    Posted date: 2016-03-15
    Communication number: 5180-372633 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Colin Fraser, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade, Intellectual Property, Health, Science and Technology, Research and Development
    Communication date: 2016-02-25
    Posted date: 2016-03-15
    Communication number: 5180-372646 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Lametti, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade, Intellectual Property, Health, Science and Technology, Research and Development
    Communication date: 2016-02-18
    Posted date: 2016-03-15
    Communication number: 5180-372641 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jacques Gourde, député | House of Commons

    Subject Matter of the communication: Intellectual Property, Health, Science and Technology, Research and Development
    Communication date: 2016-01-27
    Posted date: 2016-02-22
    Communication number: 5180-370052 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Faycal El-Khoury, député | House of Commons
    • Angelo Iacono, député | House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology, Research and Development
    Communication date: 2016-01-26
    Posted date: 2016-02-22
    Communication number: 5180-370051 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Philippe Champagne, Secrétaire parlementaire | Finance Canada (FIN)
    • Sylvie Boucher, député | House of Commons

    Subject Matter of the communication: Intellectual Property, International Relations
    Communication date: 2016-01-25
    Posted date: 2016-02-22
    Communication number: 5180-370050 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mario Lavoie, Directeur des Opérations | Infrastructure, Collectivités et Affaires gouvernementales | Infrastructure Canada (INFC)

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2015-06-03
    Posted date: 2015-07-15
    Communication number: 5180-358236 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francois Pilon, député | House of Commons

    Subject Matter of the communication: Intellectual Property
    Communication date: 2015-06-02
    Posted date: 2015-07-15
    Communication number: 5180-358235 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marc Aurele Fortin, député | House of Commons

    Subject Matter of the communication: Intellectual Property
    Communication date: 2015-06-02
    Posted date: 2015-07-15
    Communication number: 5180-358233 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rahul Bedi, Attaché politique | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2015-03-11
    Posted date: 2015-04-29
    Communication number: 5180-352421 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francois Desmarais, Attaché politique | Industry Canada

    Subject Matter of the communication: Intellectual Property
    Communication date: 2015-03-05
    Posted date: 2015-04-29
    Communication number: 5180-352420 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Lapointe, Dépuité | Chambre des communes | House of Commons

    Subject Matter of the communication: Intellectual Property, Health, Science and Technology, Research and Development
    Communication date: 2015-02-24
    Posted date: 2015-03-18
    Communication number: 5180-349613 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Lapointe, Député | Chambre des communies | House of Commons

    Subject Matter of the communication: Intellectual Property, Health, Science and Technology, Research and Development
    Communication date: 2015-02-05
    Posted date: 2015-03-18
    Communication number: 5180-349612 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Desmarais, Attaché politique du Ministre de l'Industrie | Industrie Canada | Industry Canada

    Subject Matter of the communication: Health
    Communication date: 2015-02-05
    Posted date: 2015-03-18
    Communication number: 5180-349611 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Philip Jennings, Sous-ministre adjoint | Industrie Canada | Industry Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology, Research and Development
    Communication date: 2015-02-02
    Posted date: 2015-03-18
    Communication number: 5180-349610 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Don Davis, Member of Parliament | House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology, Research and Development
    Communication date: 2015-01-27
    Posted date: 2015-02-24
    Communication number: 5180-347896 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Chrystia Freeland, Member of Parliament | House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology, Research and Development
    Communication date: 2015-01-27
    Posted date: 2015-02-24
    Communication number: 5180-347894 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Lapointe, Député | Chambre des communes | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-11-05
    Posted date: 2014-12-21
    Communication number: 5180-342657 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Supriya Sharma, Sous-ministre adjointe déléguée intérimaire | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2014-07-17
    Posted date: 2014-08-15
    Communication number: 5180-331634 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marion Lavoie, Attaché politique ministre Infrastructure, Collectivités et Affaires Gouv. | House of Commons

    Subject Matter of the communication: Intellectual Property, Health, Science and Technology, Research and Development
    Communication date: 2014-06-25
    Posted date: 2014-07-23
    Communication number: 5180-330506 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maurice Rioux, Attaché politique du député de Bourassa | House of Commons

    Subject Matter of the communication: Intellectual Property, Health, Science and Technology, Research and Development
    Communication date: 2014-06-20
    Posted date: 2014-07-23
    Communication number: 5180-330505 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maurice Rioux, Attaché politique du député de Bourassa | House of Commons

    Subject Matter of the communication: Intellectual Property, Health, Science and Technology
    Communication date: 2014-06-13
    Posted date: 2014-07-23
    Communication number: 5180-330504 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hedy Fry, Member of Parliament | House of Commons
    • Rob Merryfield, Member of Parliament | House of Commons
    • Francois Pilon, Member of Parliament | House of Commons
    • Terence Young, Member of Parliament | House of Commons
    • Carol Hughes, Member of Parliament | House of Commons
    • Kirsty Duncan, Member of Parliament | House of Commons
    • Kelvin Ogilvie, Member of Parliament | House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology, Research and Development
    Communication date: 2014-05-12
    Posted date: 2014-06-26
    Communication number: 5180-328891 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Carol Hughes, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology, Research and Development
    Communication date: 2014-05-01
    Posted date: 2014-06-26
    Communication number: 5180-328892 (amended from 5180-328889) View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kelvin Ogilvie, Sénateur | Sénat du Canada | Senate of Canada

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2014-04-30
    Posted date: 2014-05-31
    Communication number: 5180-326149 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Harper, Premier ministre | Prime Minister's Office (PMO)

    Subject Matter of the communication: International Trade, Intellectual Property, International Relations, Research and Development
    Communication date: 2014-02-28
    Posted date: 2014-03-19
    Communication number: 5180-319830 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francois Pilon, Député | Opposition | House of Commons
    • Alain Giguère, Député | Opposition | House of Commons

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2014-02-19
    Posted date: 2014-03-18
    Communication number: 5180-319816 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phelip Jennings, Sous-ministre associé | Industry Canada

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2014-02-18
    Posted date: 2014-03-18
    Communication number: 5180-319814 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francois Lapointe, Député | House of Commons

    Subject Matter of the communication: Health, Science and Technology, Research and Development
    Communication date: 2014-02-10
    Posted date: 2014-03-18
    Communication number: 5180-319812 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alain Giguère, Député | Chambre des Communes (Opposition) | House of Commons

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2013-12-10
    Posted date: 2014-01-23
    Communication number: 5180-313892 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Pilon, Député | Chambre des Communes (Opposition) | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2013-12-09
    Posted date: 2014-01-23
    Communication number: 5180-313891 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Lapointe, Député | Chambre des Communes (Opposition) | House of Commons

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2013-12-04
    Posted date: 2014-01-23
    Communication number: 5180-313890 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Philip Jennings, Assistant Deputy Minister | Industrie Canada | Industry Canada

    Subject Matter of the communication: Research and Development
    Communication date: 2012-11-19
    Posted date: 2012-12-20
    Communication number: 5180-251949 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Patrick Stewart, Actiing Senrio Executive Director | Therapeutic Products Directorate | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2012-10-24
    Posted date: 2012-11-20
    Communication number: 5180-246169 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francois Pilon, Member of the House of Commons | House of Commons

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2012-10-19
    Posted date: 2012-11-20
    Communication number: 5180-246170 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alain Giguère, Député | House of Commons
    • Rosane Doré, Député | House of Commons

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2012-10-18
    Posted date: 2012-11-20
    Communication number: 5180-246209 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phil Jennings, Associate Assistant Deputy Minister | Industry Canada | Industry Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2012-09-13
    Posted date: 2012-10-19
    Communication number: 5180-241870 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Claude Carignan, Senator | Senate of Canada

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2012-06-29
    Posted date: 2012-07-20
    Communication number: 5180-231329 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jacques Gourde, Member of the House of Commons | House of Commons | House of Commons

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2012-06-06
    Posted date: 2012-07-20
    Communication number: 5180-231309 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Claude Nolin, Senator | Senate | Senate of Canada

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2012-05-30
    Posted date: 2012-06-20
    Communication number: 5180-227973 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Patrick Stewart, Acting Senior Executive Director | Director General's Office | Health Canada (HC)
    • Barbara Sabourin, Director General | Director General's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2012-05-23
    Posted date: 2012-07-20
    Communication number: 5180-231349 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Merrifield, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2012-05-15
    Posted date: 2012-06-20
    Communication number: 5180-227972 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jacques Gourde, Député | Chambre des communes | House of Commons

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2012-04-24
    Posted date: 2012-06-01
    Communication number: 5180-225109 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Lapointe, Député | Chambre des Communes | House of Commons

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2012-04-04
    Posted date: 2012-06-01
    Communication number: 5180-225107 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Claude Nolin, Sénateur | Sénat du Canada | Senate of Canada

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2012-03-29
    Posted date: 2012-04-27
    Communication number: 5180-220447 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Harper, Premier Ministre | Prime Minister's Office (PMO)

    Subject Matter of the communication: Science and Technology
    Communication date: 2012-01-26
    Posted date: 2012-02-17
    Communication number: 5180-208247 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Lapointe, Député NPD - Montmagny - L'Islet - Kamouraska - Rivière du Loup | House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-12-06
    Posted date: 2012-01-26
    Communication number: 5180-204648 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Raymond Côté, Député NPD - Beauport Limoilou | House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-12-06
    Posted date: 2012-01-26
    Communication number: 5180-204647 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hélène Leblanc, Député NPD - Lasalle-Émard | House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-12-05
    Posted date: 2012-01-22
    Communication number: 5180-204147 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Lapointe, Député | House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-11-28
    Posted date: 2011-12-22
    Communication number: 5180-201217 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mathieu Ravigna, Député | House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-11-18
    Posted date: 2011-12-22
    Communication number: 5180-201216 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lysianne Blanchette, Député | International Development Research Centre (IDRC)
    • Claude Carignan, Senateur | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-11-15
    Posted date: 2011-12-22
    Communication number: 5180-201215 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alain Giguere, Député | House of Commons
    • François Pilon, Député | House of Commons
    • Rosane Dore-Lefebvre, Député | House of Commons

    Subject Matter of the communication: International Trade, Intellectual Property, Health, Science and Technology
    Communication date: 2011-11-09
    Posted date: 2011-12-22
    Communication number: 5180-201208 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • James Rajotte, Député | House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-11-03
    Posted date: 2011-12-22
    Communication number: 5180-201214 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mike Sullivan, Deputy - NPD - York-South Weston | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-27
    Posted date: 2011-11-16
    Communication number: 5180-195299 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Denis Lebel, Ministre | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195295 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Christian Paradis, Ministre de l'Industrie et Ministre d'État (agriculture) | Industry Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195294 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Steven Blaney, Ministre des Anciens Combattants | Veterans Affairs Canada (VAC)

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195284 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maxime Bernier, député | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195275 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Claude Carignan, Sénateur - division sénatoriale, Mille Îles | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195274 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Sénateur - division sénatoriale, De La Durantaye | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195273 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Suzanne Fortin-Duplessis, Sénateur - division Rougemont | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195272 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Larry Smith, Sénateur - division sénatoriale, Saurel | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195270 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michel Rivard, Sénateur - division sénatoriale, Les Laurentides | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195268 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre-Claude Nolin, Sénateur - division sénatoriale, Salaberry | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195267 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jacques Demers, Sénateur - division sénatoriale, Rigaud | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195266 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre-Hugues Boisvenu, Senateur - division sénatoriale, Lasalle Quebec | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195265 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jacques Gourde, Député de Lotbinière-Chute de la Chaudière | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-10-26
    Posted date: 2011-11-16
    Communication number: 5180-195264 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Collin Carrie, Député du parti conservateur et secrétaire parlementaire à la santé | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-09-30
    Posted date: 2011-10-17
    Communication number: 5180-190184 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alain Giguère, Député NPD | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-09-08
    Posted date: 2011-10-17
    Communication number: 5180-190167 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Louise Girouard, Directeur des Politiques, relations avec les Stakeholders | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-08-29
    Posted date: 2011-09-19
    Communication number: 5180-186824 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François Pilon, Député NPD | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-08-18
    Posted date: 2011-09-19
    Communication number: 5180-186806 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jose Numez Melo, Député NPD | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-08-16
    Posted date: 2011-09-19
    Communication number: 5180-186784 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rosanne Doré Lefebvre, Député NPD | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-08-16
    Posted date: 2011-09-19
    Communication number: 5180-186744 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Harper, Prime Minister | Prime Minister's Office (PMO)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2011-06-09
    Posted date: 2011-07-22
    Communication number: 5180-176067 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Philip Jennings, Associate Deputy Minister | Industry Canada
    • Philip Jennings, Associate Deputy Minister | Industry Canada

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2011-05-12
    Posted date: 2011-06-15
    Communication number: 5180-173545 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bernard Patry, Deputy | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-02-28
    Posted date: 2011-03-16
    Communication number: 5180-169037 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Claude Carignan, Senator | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-02-01
    Posted date: 2011-03-16
    Communication number: 5180-169033 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Claude Carignan, Senator | Senate of Canada

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2011-01-13
    Posted date: 2011-02-16
    Communication number: 5180-166167 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tony Clement, Minister of Industry | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2011-01-13
    Posted date: 2011-02-16
    Communication number: 5180-166166 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nicole Demers, Député | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-11-29
    Posted date: 2010-12-15
    Communication number: 5180-162373 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Renart Ana, Deputy Chief Negotiator for Canada in the CETA Negotiations | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-11-29
    Posted date: 2010-12-15
    Communication number: 5180-162366 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Chief Negotiator for Canada in the CETA Negotiations | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2010-11-29
    Posted date: 2010-12-15
    Communication number: 5180-162338 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Claude Carignan, sénateur | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-20
    Posted date: 2010-11-12
    Communication number: 5180-159369 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nicole Demers, député | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-14
    Posted date: 2010-11-12
    Communication number: 5180-159368 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Suzanne Fortin-Duplessis, sénatrice | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159371 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Josée Verner, Ministre | Privy Council Office (PCO)

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159370 (amended from 5180-159347) View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michel Rivard, sénateur | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159362 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jacques Demers, sénateur | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159356 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrée Champagne, sénatrice | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159355 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Claude Carignan, senateur | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159354 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patrick Brazeau, sénateur | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159353 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre-Hughes Boisvenu, sénateur | Senate of Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159352 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Boucher Sylvie, député | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159351 (amended from 5180-159340) View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Christian Paradis, Ministre | Natural Resources Canada (NRCan)

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159350 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Pierre Blackburn, Ministre | Veterans Affairs Canada (VAC)

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159348 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Denis Lebel, Ministre d'État | Federal Office of Regional Development – Quebec (FORD[Q])

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159346 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Généreux Bernard, député | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159345 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Blaney Steven, député | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159343 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jacques Gourde, député | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159342 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Daniel Petit, Député | Members of the House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2010-10-06
    Posted date: 2010-11-12
    Communication number: 5180-159341 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Luc Malo, Member of Parliament, Bloc Québécois | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2010-09-23
    Posted date: 2010-10-04
    Communication number: 5180-155967 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Bruinooge, Conservative Member of Parliament | Aboriginal Affairs and Northern Development Canada
    • Rob Bruinooge, Conservative Member of Parliament | Aboriginal Affairs and Northern Development Canada

    Subject Matter of the communication: Health, Aboriginal Affairs
    Communication date: 2010-09-20
    Posted date: 2010-10-04
    Communication number: 5180-155966 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Peter Van Loan, Minister of International Trade | International Trade Ministry

    Subject Matter of the communication: International Trade, Industry, Intellectual Property, Health, Science and Technology
    Communication date: 2010-03-10
    Posted date: 2010-04-12
    Communication number: 5180-145598 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Colin Carrie, Parliamentary Secretary to the Minister of Health | Minister of Health
    • Colin Carrie, Parliament Secretary to the Minister of Health | Minister of Health

    Subject Matter of the communication: Health
    Communication date: 2010-03-09
    Posted date: 2010-04-08
    Communication number: 5180-145396 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Morris Rosenberg, Deputy Minister | Health Canada (HC)
    • Morris Rosenberg, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Industry, Health
    Communication date: 2010-03-09
    Posted date: 2010-04-08
    Communication number: 5180-145394 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Scott Tessier, Chief of Staff | Office of the Minister of Health | Health Canada (HC)
    • Leah Canning, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Glenda Yeates, Associate Deputy Minister | Health Canada (HC)
    • Richard Dicerni, Deputy Minister | Industry Canada

    Subject Matter of the communication: Health
    Communication date: 2010-02-03
    Posted date: 2010-03-01
    Communication number: 5180-140855 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lawrence Cannon, Minister of Foreign Affairs and International Trade Canada | Foreign Affairs and International Trade Canada (DFAITC)
    • Martin Dumont, Chief of Staff | Office of the Minister of State (Seniors), HRSDC | Human Resources and Social Development Canada (HRSDC)
    • Tony Clement, Minister of Industry | Industry Canada | Industry Canada
    • Dave Forestell, Policy Advisor | Prime Minister's Office | Privy Council Office (PCO)

    Subject Matter of the communication: Health
    Communication date: 2010-02-02
    Posted date: 2010-03-01
    Communication number: 5180-140854 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lawrence Cannon, Ministre des Affaires étrangères | Affraires étrangères | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Science and Technology
    Communication date: 2009-07-08
    Posted date: 2009-08-21
    Communication number: 5180-118414 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marc Vallieres, Chief of Staff | Office of the Minister, Public Works and Government Services Canada (PWGSC) | Public Works and Government Services Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2009-06-19
    Posted date: 2009-07-15
    Communication number: 5180-114087 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bruce Wunchester, Conseiller en politiques | Cabinet du ministre des travaux publics et des services gouvernmentaux | Public Works and Government Services Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2009-05-29
    Posted date: 2009-06-12
    Communication number: 5180-109281 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Policy Advisor | Cabinet of the Minister of Industry Canada | Industry Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2009-04-22
    Posted date: 2009-05-14
    Communication number: 5180-105715 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lawrence Cannon, Ministre des Affaires étrangères | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Science and Technology
    Communication date: 2008-12-22
    Posted date: 2009-01-14
    Communication number: 5180-90260 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Rancourt, Conseiller en politiques | Cabinet du Ministre des Finances | Finance Canada (FIN)

    Subject Matter of the communication: Science and Technology
    Communication date: 2008-12-04
    Posted date: 2009-01-14
    Communication number: 5180-90259 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Amy Ringdhal, Conseillère en politiques | Cabinet du Ministre des Finances | Finance Canada (FIN)

    Subject Matter of the communication: Science and Technology
    Communication date: 2008-12-04
    Posted date: 2009-01-14
    Communication number: 5180-90258 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Barbara Ouellet, Directrice Exécutive | Conseil d'examen du prix des médicaments brevetés | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2008-08-13
    Posted date: 2008-09-15
    Communication number: 5180-81076 View associated registration
  • sanofi-aventis Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Martin Dumont, Conseiller en politiques | Bureau du ministre de l'industrie | Industry Canada

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2008-07-03
    Posted date: 2008-08-29
    Communication number: 5180-78538 View associated registration

Public offices held:


Public offices held: Myrtho-Emmanuelle Drouin

Adjointe spéciale, Affaires Parlementaires, Cabinet du Premier Ministre (1994-1999)
Date Modified: